Αποτελέσματα Αναζήτησης
21 Απρ 2023 · The epidemiology, clinical features, diagnosis, and treatment of infections due to K. pneumoniae will be reviewed here. The microbiology and pathogenesis of K. pneumoniae infection are discussed separately.
- Keri K Hall, Md, Ms
Clinical features, diagnosis, and treatment of Klebsiella...
- Tsay Rw, SIU Lk, Fung Cp, Chang Fy. Characteristics of Bacteremia Between Community-Acquired and Nosocomial Klebsiella Pneumoniae Infection: Risk Factor for Mortality and The Impact of Capsular Serotypes as a Herald for Community-Acquired Infection. Arch Intern Med 2002; 162:1021
Medline ® Abstract for Reference 15 of 'Clinical features,...
- Keri K Hall, Md, Ms
20 Ιουλ 2023 · Identify the most common cause of hospital-acquired pneumonia in the United States. Recall patients most likely to get Klebsiella pneumonia. Review the evaluation and treatment of patients with Klebsiella pneumonia and the interprofessional team's role in managing patients with this condition.
16 Οκτ 2018 · Treatment of Klebsiella pneumonia has discrepant results. For patients with severe infections, a clinically prudent approach is the use of an initial short course (48-72 h) of combination therapy...
Until very recently, the pipeline of new drugs for the treatment of multidrug-resistant gram-negative pathogens had been described as “dry”. However, a number of new drugs with in vitro activity against multidrug-resistant strains of K. pneumoniae are now in development.
18 Αυγ 2022 · At stable state, cefiderocol 2 g advised as a 60 min infusion in each 8 h in healthy adults attains a peak serum concentration (Cmax) of 153 mg/mL and reduces half-life (t) of 2.72 h and systemic clearance (Cl) of 3.89 L/h. Cefiderocol is mainly eliminated unaffected via the kidneys [39].
27 Σεπ 2017 · The emergence of pandrug-resistant strains of K. pneumoniae highlights the critical need for consistent implementation of effective strategies for prevention of transmission and infection and for the development of new antimicrobials with activity against these emerging pathogens.
Abstract. Simple Summary. Numerous diseases, such as liver abscesses, bacteremias, pneumonia, and urinary tract infections, are caused by Klebsiella pneumonia (K. pneumonia). Historically, immunocompromised patients have been the main target of serious infections induced by K. pneumoniae.
